Ohcanbohtosat - Ming‐Shyang Huang

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells

    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells Dahkki An-Fu Lee, Man‐Chin Chen, Chao‐Ju Chen, Chih‐Jen Yang, Ming‐Shyang Huang, Yu‐Peng Liu

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    <scp>PCAF</scp>‐mediated acetylation of <scp>ISX</scp> recruits <scp>BRD</scp>4 to promote epithelial‐mesenchymal transition

    <scp>PCAF</scp>‐mediated acetylation of <scp>ISX</scp> recruits <scp>BRD</scp>4 to promote epithelial‐mesenchymal transition Dahkki Li‐Ting Wang, Kwei‐Yan Liu, W.Y. Jeng, Cheng‐Ming Chiang, Chee‐Yin Chai, Shyh‐Shin Chiou, Ming‐Shyang Huang, Kazunari K. Yokoyama, Shen‐Nien Wang, Shau‐Ku Huang, Shih‐Hsien Hsu

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]

    Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients... Dahkki Shih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, Hao‐Chien Wang, Jeng‐Yuan Hsu, Shih‐Feng Liu, Ming-Shyang Huang, Cheng-Hung Lee, Ching‐Hsiung Lin, Liang‐Wen Hang, Yu‐Chih Liu, Kuang‐Yao Yang, Jia-Horng Wang

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Errata/Corrigenda
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: